InvestorsHub Logo
Followers 4
Posts 253
Boards Moderated 0
Alias Born 02/05/2014

Re: Pyrrhonian post# 35422

Monday, 06/01/2015 5:40:42 PM

Monday, June 01, 2015 5:40:42 PM

Post# of 703712
Thank you Pyrr! Thank you for many articles and postings NWBO related. I know from my own experience the effect NWBO has over 'new to NWBO' investors. Luckily, I did my own due diligence and as a part of the DD I came across your posts here on ihub. Among every poster here, your posts stood out and helped me fill in the blanks with NWBO. I really liked the one of your two articles late last year that statistically analyzed DCVAX-L data for efficacy. It was inspiring and the sole catalyst for NWBO's subsequent rally on no company news.Northwest Biotherapeutics: DCVax-Direct Validation And Updated DCVax-L Ph III Modeling That article is the only reason why I am still interested in NWBO. I had my reservations about Direct long before it went to Ph I. How could something like Direct with no exposure to the tumor, supposed to be any different than a company like IMUC? Plainly speaking of course. With your well documented apprehensions in regards to the Direct data, the decision was easy for me to sell all of my NWBO shares and look to get back in once the pps goes below a certain point. If I am able to get back in at the right price, my only real worry would be that Direct implodes before L gets approved. Is there any way to model that??


Oh and one more thing. My apologies in the perception that you are me and I am you. I am not sure how that started or why.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News